HRA000199
Title:
Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in patients with cirrhosis
Release date:
2021-04-16
Description:
A case control study recruited patients with HCC, liver cirrhosis and healthy controls. Four genomic features of cell-free DNA (cfDNA), including nucleosome footprint (NF), fragmentation, base mismatch (BM) and 5-hydroxymethylcytosines (5hmc) were profiled by low-pass whole genome sequencing (2x) and hydroxymethylcytosines enrichment sequencing. Training and validation cohorts helped develop the integrated diagnostic model and test cohort was used to evaluate its performance.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
hepatocellular carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Berryoncology_HCC_data
Contact person:
su xiaoxing
Email:
suxiaoxing001@berryoncology.com
Description:
Berryoncology HCC data
Individuals & samples
Submitter:   chen lei / chenlein39@hotmail.com
Organization:   Eastern hepatobiliary surgery hospital
Submission date:   2020-05-22
Requests:   4